Gulf War veterans' complaints of unexplained symptoms are psychological - stress reactions to combat rather than real physical illness.

They came home in the spring of 1991 with a coalition victory and, for many of them, something else they could not name. Veterans of Operation Desert Storm began reporting symptoms within months of their return: persistent fatigue, joint and muscle pain, cognitive difficulties that family members described as a kind of mental fog, skin rashes, chronic headaches, sleep disturbances, and gastrointestinal problems that did not resolve. The symptoms were real to the people experiencing them. Finding a doctor who agreed proved considerably harder.

The Department of Defense and the Department of Veterans Affairs were not, in 1991 and 1992, prepared to recognize what they were hearing. The Gulf War had been the briefest large-scale American combat operation in decades, one hundred hours of ground combat following weeks of aerial bombardment. Casualties had been remarkably low. The official narrative was a military and technological success story. Against this backdrop, veterans reporting diffuse, unexplained symptoms presented an institutional difficulty. Medical personnel at VA hospitals frequently documented the complaints without a diagnosis. Some physicians told veterans that the symptoms were psychological, stress reactions to combat, post-traumatic effects that would resolve with time and treatment. The phrase it's all in your head appears in enough veterans' accounts of their early VA experiences that it became a refrain.

The dismissal was made easier by the absence of an obvious exposure. Unlike veterans of the world wars, who had encountered recognized chemical agents, Gulf War veterans had not been exposed to anything that appeared on existing toxicology lists. The exposure picture was considerably more complicated than this assumption suggested. Soldiers had been given pyridostigmine bromide pills as prophylaxis against possible nerve agent attack, the first time the U.S. military had issued a pharmaceutical countermeasure to troops at scale. Aerial bombardments had destroyed Iraqi munitions storage facilities, potentially releasing chemical agent plumes whose composition was not fully documented. Pesticides used in the theater included organophosphates. Depleted uranium from armor-piercing rounds had contaminated environments where some soldiers worked. The combined exposure profile of a Gulf War veteran was genuinely novel and had not been studied.

In 1994, the Institute of Medicine released its first formal evaluation of the Gulf War health programs run by the Department of Defense. The report examined data from the Comprehensive Clinical Evaluation Program and found that veterans' symptoms were real, consistent, and not fully explained by the stress and psychological frameworks that had been applied to them. The IOM stopped short of identifying a single cause but established that the pattern of multi-symptom illness, which would later be formally termed Gulf War Illness, was a recognizable clinical entity.

Subsequent research accumulated across the following decade. A 2008 report by the Research Advisory Committee on Gulf War Veterans' Illnesses, a congressionally mandated body, concluded that Gulf War Illness was a genuine condition affecting approximately 175,000 to 250,000 veterans and that the evidence pointed toward toxic exposures, particularly pyridostigmine bromide and pesticide combinations, as likely contributors. The VA formally recognized Gulf War Illness as a service-connected condition, entitling veterans to disability benefits for the full range of associated symptoms.

The veterans who reported symptoms in 1991 were not mistaken about their experience, and the institutions that characterized those experiences as psychological stress were not conducting science, they were managing a narrative. The research eventually closed the gap, at a cost borne by the people who had been waiting for it.